Diseases [C] » Infections [C01] » Toxemia
Description
A condition produced by the presence of toxins or other harmful substances in the BLOOD. MeSH
Hierarchy View
Subtype Terms (1)
Endotoxemia
51 drugs (22 approved, 29 experimental)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (61)
Association Pour La Promotion A Tours De La Reanimation Medicale
Canadian Institutes of Health Research (CIHR)
Los Angeles Biomedical Research Institute
National Health and Family Planning Commission, P.R.China
National Hospital Organization Kyoto Medical Center
National Institute for Health Research, United Kingdom
National Institute of General Medical Sciences (NIGMS)
Sir Takhtasinhji General Hospital
State Hospital, Baden, Switzerland
Sunnybrook Health Sciences Centre
Organization Involved with Phase 3 Indications (113)
Aragon Institute of Health Sciences
Aristotle University of Thessaloniki
Bill and Melinda Gates Foundation
Case Western Reserve University
Hormozgan University of Medical Sciences
Hospital general Universitario de Ciudad Real
Hospital Italiano de Buenos Aires
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Institute Tropical Medicine Belgium and MRC Unit in The Gambia
Institut National de la Santé Et de la Recherche Médicale, France
Instituto de Medicina Integral Professor Fernando Figueira
International Center for Diarrheal Disease Research
Lata Medical Research Foundation, Nagpur, India
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Oregon Health and Science University
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
Postgraduate Institute of Medical Education and Research
Scandinavian Critical Care Trials Group
Shanghai University of Traditional Chinese Medicine
United States Agency for International Development
Universidad Nacional de La Plata
University of Alabama, Birmingham
University of Castilla-La Mancha
Organization Involved with Phase 2 Indications (50)
Boryung Pharmaceutical Company
Community Medical Center, Toms River, NJ
Hamilton Health Sciences Corporation
Hellenic Institute for the Study of Sepsis
Instituto Mexicano del Seguro Social
Moorgreen Hospital, Southampton
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (28)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.